GLP-1 Market
LLY $1184.78 ▲ +0.1% NVO $38.71 ▼ -0.2% PFE $28.72 ▲ +0.2% VKTX $33.03 ▼ -7.1% KLRA $11.12 ▼ -0.9% GPCR $35.06 ▼ -2.4% RHHBY $53.34 ▼ -2.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Etonogestrel/ethinyl estradiol vaginal ring

Company
Andrea Roe, MD, MPH
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 29, 2026

Trial details
  • Completed NCT NCT00269620

    PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra

    Not yet reported University of Pittsburgh 500 participants Est. completion 2006-12 10 sites Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT00369967

    Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

    Not yet reported Virginia Commonwealth University 48 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Contraception Desired
    View official trial listing →
  • Completed NCT NCT00374387

    Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire

    Not yet reported University Hospital, Ghent 150 participants Est. completion 2011-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00475553

    Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

    Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 site
    Other conditions: Breakthrough Bleeding, Breakthrough Spotting
    View official trial listing →
  • Completed NCT NCT00524771

    Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)

    Center for Epidemiology and Health Research, Germany 34100 participants Est. completion 2012-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00565240

    Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

    Not yet reported University of Saskatchewan 41 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Ovarian Follicle
    View official trial listing →
  • Completed NCT NCT00612508

    Hormonal Contraception and Vaginal Health

    Not yet reported Oregon Health and Science University 14 participants Est. completion 2008-05 1 site
    Other conditions: Contraceptive Usage, Vaginal Epithelial Disruption
    View official trial listing →
  • Completed NCT NCT00635570

    Acceptability of the NuvaRing Among Students

    Not yet reported University of Chicago 273 participants Est. completion 2009-07 3 sites
    Other conditions: Birth Control Compliance
    View official trial listing →
  • Completed NCT NCT00710606

    Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

    Not yet reported Columbia University 40 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01044056

    A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

    Not yet reported Organon and Co 24 participants Est. completion 2004-06
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01087879

    The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism

    Not yet reported University of Oulu 45 participants Est. completion 2011-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01266759

    Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia

    Not yet reported Mansoura University 95 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Menorrhagia
    View official trial listing →
  • Completed NCT NCT01277211

    A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

    Not yet reported Organon and Co 983 participants Est. completion 2013-09-18 Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT01298128

    NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment

    Not yet reported University of Toronto 70 participants Est. completion 2010-12 Stand-alone
    Other conditions: Infertility, In-vitro Fertilization
    View official trial listing →
  • Status unknown NCT NCT01384331

    New Treatments for Troublesome Bleeding in Implanon Users

    Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 site
    Other conditions: Menstrual Problem
    View official trial listing →
  • Status unknown NCT NCT01448291

    Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers

    Not yet reported Eastern Virginia Medical School 30 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Vaginosis, Bacterial
    View official trial listing →
  • Completed NCT NCT01490190

    Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

    Not yet reported Organon and Co 252 participants Est. completion 2012-12-05 Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT01638767

    NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles

    Not yet reported Clinique Ovo 7 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01709318

    A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

    Not yet reported Organon and Co 666 participants Est. completion 2013-10-22
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01796613

    Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy

    Not yet reported, Not yet reported Institute of Tropical Medicine, Belgium 120 participants Est. completion 2014-03 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01903031

    Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT02275546

    Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)

    Not yet reported Organon and Co 164 participants Est. completion 2015-04-10
    Other conditions: Contraception: Optional Applicator for Insertion of Vaginal Ring
    View official trial listing →
  • Completed NCT NCT02367833

    Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis

    Not yet reported Penn State University 60 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Bone; Disorder, Development and Growth
    View official trial listing →
  • Status unknown NCT NCT02404038

    A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

    Not yet reported Desmond Tutu HIV Centre 131 participants Est. completion 2020-02-28 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02432404

    Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

    Not yet reported University of Washington 81 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Bacterial Vaginosis
    View official trial listing →
  • Completed NCT NCT02445989

    Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity

    Not yet reported University of Washington 120 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Bacterial Vaginosis, HIV
    View official trial listing →
  • Completed NCT NCT02529683

    Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

    Not yet reported Centers for Disease Control and Prevention 200 participants Est. completion 2015-08 Stand-alone
    Other conditions: Hormonal Contraception
    View official trial listing →
  • Status unknown NCT NCT03120728

    Application for the Etonogestrel/Ethinyl Estradiol Ring

    Not yet reported University of Southern California 36 participants Est. completion 2018-07-01 2 sites
    Other conditions: Emergency Contraception, Healthy, Reproductive Age Women
    View official trial listing →
  • Completed NCT NCT04257500

    Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS

    Not yet reported Andrea Roe, MD, MPH 22 participants Est. completion 2025-08-22 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT05360550

    A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females

    Not yet reported Lupin Research Inc 26 participants Est. completion 2023-01-12 1 site Stand-alone
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT05360576

    An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

    Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 site Stand-alone
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT05994599

    Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

    Not yet reported Evestra Inc. 36 participants Est. completion 2023-12-11 1 site
    Other conditions: Healthy Women, Female, Contraception
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Etonogestrel/ethinyl estradiol vaginal ring, NuvaRing

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.